Supplementary Materials. Prognostic and predictive value of microsatellite instability (MSI) status among patients with colorectal cancer
收藏DataCite Commons2021-10-05 更新2025-04-15 收录
下载链接:
https://future-science-group.figshare.com/articles/dataset/Supplementary_Materials_Prognostic_and_predictive_value_of_microsatellite_instability_MSI_status_among_patients_with_colorectal_cancer/16740592
下载链接
链接失效反馈官方服务:
资源简介:
Supplementary figure 1. Overall survival in (A) stage II CRC and (B) stage III patients according to MSI status.<br>Supplementary figure 2. Stage II CRC with high-risk features.<br>Supplementary figure 3. Overall survival in (A) MSI-H and (B) MSI-S stage II CRC patients with highest-risk features according to chemotherapy.<br>Supplementary figure 4. Stage II CRC without high-risk features.<br>Supplementary figure 5. Overall survival in (A) MSI-H stage III CRC patients with low-risk features and (B) MSI-H stage III CRC patients with high-risk features according to chemotherapy.<br>Supplementary figure A. Patient selection.<br>Supplementary figure B. Histogram for raw data and matched data (stage II MSI-H and high-risk features).<br>Supplementary figure C. Histogram for raw data and matched data (stage II MSI-H and without high-risk features).<br>Supplementary figure D. Histogram for raw data and matched data (stage II MSI-S and without high-risk features).<br>Supplementary Table A. Baseline characteristics of MSI-H stage II CRC patients with high-risk features according to chemotherapy after propensity score matching.<br>Supplementary Table B. Baseline characteristics of MSI-H stage II CRC patients without high-risk features according to chemotherapy after propensity score matching.<br>Supplementary Table C. Baseline characteristics of MSI-L stage II CRC patients without high-risk features according to chemotherapy after propensity score matching.<br>Supplementary Table D. Multivariate analysis for MSI known status stage II & III CRC patients.<br>
补充图1:按微卫星不稳定(Microsatellite Instability, MSI)状态分组的(A)II期结直肠癌(Colorectal Cancer, CRC)及(B)III期结直肠癌患者的总生存期;补充图2:伴高危特征的II期结直肠癌;补充图3:按化疗情况分组的、携带最高危特征的(A)高微卫星不稳定(MSI-High, MSI-H)及(B)微卫星稳定(MSI-Stable, MSI-S)II期结直肠癌患者的总生存期;补充图4:无高危特征的II期结直肠癌;补充图5:按化疗情况分组的(A)伴低危特征的高微卫星不稳定III期结直肠癌患者,及(B)伴高危特征的高微卫星不稳定III期结直肠癌患者的总生存期;补充图A:患者筛选流程;补充图B:原始数据与匹配后数据的直方图(II期高微卫星不稳定且伴高危特征亚组);补充图C:原始数据与匹配后数据的直方图(II期高微卫星不稳定且无高危特征亚组);补充图D:原始数据与匹配后数据的直方图(II期微卫星稳定且无高危特征亚组);补充表A:经倾向得分匹配(Propensity Score Matching)后,伴高危特征的高微卫星不稳定II期结直肠癌患者按化疗情况分组的基线特征;补充表B:经倾向得分匹配后,无高危特征的高微卫星不稳定II期结直肠癌患者按化疗情况分组的基线特征;补充表C:经倾向得分匹配后,无高危特征的低水平微卫星不稳定(MSI-Low, MSI-L)II期结直肠癌患者按化疗情况分组的基线特征;补充表D:已知微卫星状态的II期及III期结直肠癌患者的多因素分析
提供机构:
Future Science Group
创建时间:
2021-10-05



